About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...

A newly approved drug for type 2 diabetes and kidney disease, sotagliflozin, has shown remarkable benefits in reducing the ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

In today’s digital world, access to quality healthcare should be fast, easy, and convenient. RescueMD is redefining primary care, high blood pressure management, and diabetes treatment using ...

Having high blood pressure—something that roughly half of Americans are living with—is a big deal. It increases the risk for ...

About 90% of U.S. adults meet the criteria for a newly recognized syndrome that comes from a combination of heart disease, ...

• Glucagon-like peptide 1 receptor agonists (GLP-1) (medicines used to lower blood glucose) probably reduce the risk of death due to any cause but may have little or no death due to a heart attack in ...

We all have them -- or at least one and need the kidney to survive. These vital organs serve as your body's way of getting ...

The deaths are also partly the result of medical successes: People are living longer, and more people are surviving heart ...

A growing body of research suggests that garlic supplementation can lower blood pressure, reduce cholesterol, and enhance ...

Five regions in the U.S. have been selected to implement a new preventive health initiative to improve care for people with a cluster of chronic conditions known as cardiovascular-kidney-metabolic ...